Guiding Computer Software Assurance (CSA) for Laboratory Information Management Systems (LIMS) in the context of Contract Development and Manufacturing Organizations (CDMO) for Cell and Gene Therapy.

## Streamlining Cell and Gene Therapy Manufacturing with a Laboratory Information Management System (LIMS)

In the rapidly evolving world of cell and gene therapy, the need for efficient, compliant, and data-driven operations is paramount. One key tool in achieving this goal is the implementation of a Laboratory Information Management System (LIMS).

Recently, a Contract Development and Manufacturing Organization (CDMO) specializing in cell and gene therapy embarked on a mission to enhance its laboratory operations by partnering with Clarkston Consulting. This collaboration aimed to implement a LIMS into the manufacturing process, with the objective of delivering high-level products and boosting laboratory efficiency.

The client, a leading player in the field, has more than 25 years of experience in viral vectors and has recognized leading solutions for the commercially approved lentiviral-based gene delivery system. With a recent expansion of its laboratories and GMP footprint on-site, the client's main target is the development and delivery of new gene therapies for viral diseases.

The focus of the collaboration included lentiviral and cell therapy research, development, and bioprocessing. To ensure the success of the project, Clarkston ensured that the LIMS solution supported a repeatable process and expected results through the documentation and testing of Computer Software Assurance (CSA) for the cell and gene therapy company.

The protocols included test scripts that mimicked the laboratory flow in the LIMS in the client environment and tested key functional and operational features of the system. Clarkston also developed the risk assessment documents for the solution and generated the Operational Qualification and Performance Qualification protocols. These steps helped to ensure compliance and functionality of the software in the long term, including assessing the validation procedures governing FDA requirements.

In addition, Clarkston assisted the client in setting validation process guidelines with a continuous improvement plan to meet current standards updates. The team supported the development of the documentation and testing of the LabVantage LIMS application to ensure it met all its intended business requirements.

While there is no specific mention of CSA guidance in the provided results for this project, CSA standards often align with international quality and safety standards. In the context of LIMS, CSA guidance would likely focus on ensuring that systems are designed and implemented to meet safety, quality, and security standards, similar to those in other regulatory environments.

In conclusion, the successful implementation of a LIMS into the manufacturing process of a cell and gene therapy CDMO can significantly improve operational efficiency, ensure compliance, and enhance data management in complex environments. The collaboration between the client and Clarkston Consulting serves as a testament to the potential benefits of such a partnership. As the field of cell and gene therapy continues to grow, it is likely that more CDMOs will turn to solutions like LIMS to stay at the forefront of innovation and maintain the highest standards of quality and safety.

The objectives of the partnership between the cell and gene therapy CDMO and Clarkston Consulting included the implementation of a Laboratory Information Management System (LIMS) to enhance laboratory efficiency and deliver high-level products.
To ensure the success of the project, Clarkston ensured that the LIMS solution supported a repeatable process, tested CSA for the cell and gene therapy company, developed risk assessment documents, and generated Operational Qualification and Performance Qualification protocols.
In addition, Clarkston assisted the client in setting validation process guidelines and developing documentation and testing for the LabVantage LIMS application to meet its intended business requirements.
CSA standards in the context of LIMS are likely to focus on ensuring systems are designed and implemented to meet safety, quality, and security standards, similar to those in other regulatory environments, such as medical-conditions, cancer, health-and-wellness, and technology.

Guiding Computer Software Assurance (CSA) for Laboratory Information Management Systems (LIMS) in the context of Contract Development and Manufacturing Organizations (CDMO) for Cell and Gene Therapy.